35 CONVERT-A multicentre randomised controlled NCRN trial comparing accelerated twice-daily and high dose once-daily thoracic radiotherapy in good performance status (PS), limited small-cell lung cancer (LD SCLC) treated concurrently with cisplatin and etoposide
Titel:
35 CONVERT-A multicentre randomised controlled NCRN trial comparing accelerated twice-daily and high dose once-daily thoracic radiotherapy in good performance status (PS), limited small-cell lung cancer (LD SCLC) treated concurrently with cisplatin and etoposide
Auteur:
Faivre-Finn, C. Lorigan, P. Blackhall, F. Ashcroft, L. Lyn, E. Lee, M. McMenemin, R. Mohammed, N. Price, A. Stephens, R. Snee, M. VanMeerbeck, J. Woll, P.